Skip to main content
. Author manuscript; available in PMC: 2020 Jan 1.
Published in final edited form as: Transpl Int. 2018 Sep 16;32(1):84–94. doi: 10.1111/tri.13338

Table 1 -.

Baseline characteristics compared between non-AA and AA recipients

Variable Overall Cohort (N=1,610) Non-AA (N=736) AA (N=874) p-Value Non-AA vs AA
Age (mean±SD) 51.7±13.9 52.8±14.3 50.8±13.4 0.004*
AA 54.3% NA NA NA
Female 39.7% 37.1% 41.9% 0.051**
BMI (mean±SD) 28.5±6.4 27.8±6.3 29.1±6.4 <0.001*
History of Hypertension 94.6% 92.1% 96.7% <0.001**
History of Diabetes 35.4% 30.4% 39.6% <0.001**
History of CAD 17.6% 17.8% 17.4% 0.831**
History of Stroke 6.3% 4.2% 8.1% 0.001**
Previous Transplant 8.9% 11.4% 6.9% 0.001**
Years on Dialysis (mean±SD) 2.9±2.8 1.8±2.0 3.9±3.0 <0.001*
HLA Mismatches, median (IQR) 4 (3,5) 4 (3.5) 5 (4.5) <0.001+
Current cPRA, median (IQR) 0 (0,11) 0 (0,0) 0 (0,25) <0.001+
Cold Ischemic Time (mean±SD) 16.4±9.6 14.8±10.5 17.8±8.5 <0.001*
Living Donor 16.8% 26.9% 6.4% <0.001**
Donor Age (mean±SD) 37.0±15.7 38.4±15.4 35.8±15.9 0.001*
Donor AA 26.7% 16.1% 35.6% <0.001**
Donor Female 14.6% 46.3% 37.6% 0.001**
KDPI (mean±SD) 48.4±26.9 47.8±27.2 48.7±26.8 0.518*
Cytolytic Induction 40.5% 37.9% 42.7% 0.050
*

Student’s t-test

**

Chi square test

+

Mann Whitney U test